A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Stadler, WM; Halabi, S; Ernstoff, MS; Barrier, R; Davila, E; Picus, J; Small, EJ

Published Date

  • July 15, 2004

Published In

Volume / Issue

  • 22 / 14

Start / End Page

  • 385S - 385S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 40th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • New Orleans, LA

Conference Start Date

  • June 5, 2004

Conference End Date

  • June 8, 2004